Clinical Trial Update: Dendritic Cell Cancer Vaccine for High-grade Glioma [Phase 2]

View source ↗

Summary

Phase 2 trial of a dendritic cell cancer vaccine for glioblastoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Dendritic Cell Cancer Vaccine (dendritic cell cancer vaccine)

Snippet

Sponsor: Activartis Biotech | Conditions: Glioblastoma Multiforme | Phase 2 | Status: COMPLETED